Norda ASA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Norda ASA with three other
pharmaceutical manufacturers in Europe:
Biotec Pharmacon ASA
sales of 71.90 million Norwegian Kroner [US$9.04 million]
(17.70 million Bulgarian Lev [US$10.62 million]
based in France
(9.08 million Euro [US$10.66 million]
of which 100%
was Research & Development).
Norda ASA reported sales of NOK 75.81 million (US$9.53 million)
December of 2016.
increase of 95.6%
versus 2015, when the company's sales were NOK 38.76 million.
This was the third consecutive year of growth at Norda ASA.